Financials

Find our consolidated key figures and our financial calendar below, or go directly to our financial reports and SEC filings

Financial Reports SEC Filings

Key Financials

Consolidated Key Figures

(thousands of €, if not stated otherwise)	Nine months ended 30 September 2024	Nine months ended 30 September 2023	Year ended 31 December 2023
Income statement
Supply revenues	19,124	–	–
Collaboration revenues	181,030	179,784	239,724
Total net revenues	200,154	179,784	239,724
Cost of sales	(19,124)	–	–
R&D expenses	(238,270)	(167,211)	(241,294)
S&M, G&A expenses	(93,190)	(87,440)	(133,965)
Other operating income	24,813	32,950	47,272
Operating loss	(125,617)	(41,916)	(88,263)
Net financial results	103,501	90,291	93,888
Taxes	1,710	(12,158)	(9,613)
Net profit/loss (-) from continuing operations	(20,406)	36,217	(3,988)
Net profit from discontinued operations, net of tax	69,181	17,921	215,685
Net profit	48,775	54,138	211,696

Income statement from discontinued operations
Product net sales	11,395	82,075	112,339
Collaboration revenues	26,041	186,989	431,465
Total net revenues	37,436	269,064	543,804
Cost of sales	(2,182)	(13,540)	(18,022)
R&D expenses	(13,600)	(144,969)	(190,177)
S&M, G&A expenses	(10,797)	(94,729)	(131,346)
Other operating income	55,167	7,136	13,003
Operating profit	66,024	22,962	217,262
Net financial results	3,255	(3,689)	499
Taxes	(98)	(1,352)	(2,076)
Net profit from discontinued operations, net of tax	69,181	17,921	215,685

Balance sheet
Cash and cash equivalents	55,523	159,375	166,803
Current financial investments	3,283,256	3,652,333	3,517,698
R&D incentives receivables	175,202	164,247	178,688
Assets	4,172,202	4,451,336	4,357,396
Shareholders’ equity	2,862,570	2,621,560	2,795,566
Deferred income	1,127,932	1,633,555	1,327,463
Other liabilities	181,700	196,221	234,367

CASH FLOW
Operational cash burn (*)	(321,278)	(343,817)	(414,824)
Cash flow used in operating activities	(260,657)	(339,104)	(405,970)
Cash flow generated from/used in (-) investing activities	152,237	(5,222)	71,186
Cash flow used in financing activities	(3,320)	(3,810)	(5,001)
Decrease in cash and cash equivalents	(111,740)	(348,136)	(339,785)
Effect of currency exchange rate fluctuation on cash and cash equivalents	453	(607)	(1,522)
Cash and cash equivalents at the end of the period	55,523	159,375	166,810

Cash and cash equivalents from continuing operations	55,523	159,375	166,803
Cash and cash equivalents included in assets classified as held for sale	–	–	7
Current financial investments at the end of the period	3,283,256	3,652,333	3,517,698
Total current financial investments and cash and cash equivalents at the end of the period	3,338,779	3,811,708	3,684,514

FINANCIAL RATIOS
Number of shares issued at the end of the period	65,897,071	65,897,071	65,897,071
Basic and diluted earnings per share	0.74	0.82	3.21
Share price at the end of the period (in €)	25.88	32.53	36.99
Total group employees at the end of the period (number)	683	1,131	1,123

(*) The operational cash burn (or operational cash flow if this liquidity measure is positive) is equal to the increase or decrease in our cash and cash equivalents (excluding the effect of exchange rate differences on cash and cash equivalents), minus:

the net proceeds, if any, from share capital and share premium increases included in the net cash flows generated from/used in (-) financing activities
the net proceeds or cash used, if any, related to the acquisitions or disposals of businesses; the acquisition of financial assets held at fair value through other comprehensive income; the movement in restricted cash and movement in current financial investments, if any, the cash advances and loans given to third parties, if any, included in the net cash flows generated from/used in (-) investing activities
the cash used for other liabilities related to the acquisition or disposal of businesses, if any, included in the net cash flows generated from/used in (-) operating activities.

Financial Reports

Annual Report? Half year report? All financial reports, right here!

Financial Reports

Financial Calendar

Date	Event	Webcast
February 12, 2025	Full year 2024 results	February 13, 2025
March 27, 2025	Annual report 2024	–
April 23, 2025	First quarter 2025 results	April 24, 2025
April 29, 2025	Annual Shareholders’ Meeting	–
July 23, 2025	Half-year 2025 results	July 24, 2025
October 22, 2025	Third quarter 2025 results	October 23, 2025

SEC Filings

SEC filings are the official documents we submit to the U.S. Securities and Exchange Commission (SEC). They contain financial and non-financial information essential for regulatory compliance and transparency.

Galapagos' SEC Filings